We are live on ! Find out more
DCM

Driehaus Capital Management Portfolio holdings

AUM $13.6B
1-Year Est. Return 173.98%
This Fund
S&P 500
This Quarter Est. Return
+4.28%
1 Year Est. Return
+173.98%
3 Year Est. Return
+706.72%
5 Year Est. Return
+1,585.86%
10 Year Est. Return
+31,592.09%
AUM
$7.69B
AUM Growth
-$228M
Cap. Flow
-$66.9M
Cap. Flow %
-0.87%
Top 10 Hldgs %
18.39%
Holding
467
New
87
Increased
134
Reduced
143
Closed
77

Top Buys

Rank Stock Value
1
CAMT icon
Camtek
CAMT
+$69.7M
2
TDW icon
Tidewater
TDW
+$49.7M
3
ONTO icon
Onto Innovation
ONTO
+$45.1M
4
NE icon
Noble Corp
NE
+$45M
5
SNPS icon
Synopsys
SNPS
+$43.5M

Top Sells

Rank Stock Value
1
DICE
DICE Therapeutics, Inc. Common Stock
DICE
+$94.7M
2
IRDM icon
Iridium Communications
IRDM
+$61.9M
3
INSP icon
Inspire Medical Systems
INSP
+$49M
4
WING icon
Wingstop
WING
+$47.9M
5
IBP icon
Installed Building Products
IBP
+$47.1M

Sector Composition

Rank Sector Weight
1 Technology 23.55%
2 Industrials 20.08%
3 Healthcare 18.28%
4 Consumer Discretionary 9.44%
5 Consumer Staples 7.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OLMA icon
326
Olema Pharmaceuticals
OLMA
$1B
$1.07M 0.01%
86,625
– –
JPM icon
327
JPMorgan Chase
JPM
$935B
$1.06M 0.01%
7,302
-915
-11% -$137K
BHVN icon
328
Biohaven
BHVN
$2.03B
$1.02M 0.01%
39,402
-396,445
-91% -$8.24M
NU icon
329
Nu Holdings
NU
$69.2B
$985K 0.01%
+135,824
New +$1.02M
VERA icon
330
Vera Therapeutics
VERA
$2.31B
$936K 0.01%
68,306
– –
ATRA icon
331
Atara Biotherapeutics
ATRA
$75.5M
$873K 0.01%
+23,598
New +$1.05M
ORIC icon
332
Oric Pharmaceuticals
ORIC
$1.15B
$871K 0.01%
+143,943
New +$1.18M
AMX icon
333
America Movil
AMX
$76.1B
$816K 0.01%
47,113
-1,768,972
-97% -$34.6M
AVGO icon
334
Broadcom
AVGO
$1.85T
$815K 0.01%
9,810
+2,470
+34% +$214K
ARWR icon
335
Arrowhead Research
ARWR
$11.9B
$792K 0.01%
29,493
-478,168
-94% -$14.6M
ROP icon
336
Roper Technologies
ROP
$38.8B
$733K 0.01%
1,513
+270
+22% +$132K
CMG icon
337
Chipotle Mexican Grill
CMG
$47.2B
$683K 0.01%
18,650
-800
-4% -$31.2K
AZN icon
338
AstraZeneca
AZN
$263B
$662K 0.01%
4,891
+2,231
+84% +$305K
UNH icon
339
UnitedHealth
UNH
$377B
$661K 0.01%
+1,311
New +$645K
NOW icon
340
ServiceNow
NOW
$115B
$635K 0.01%
5,680
– –
ORCL icon
341
Oracle
ORCL
$374B
$633K 0.01%
5,976
+2,130
+55% +$247K
NTR icon
342
Nutrien
NTR
$33.2B
$630K 0.01%
10,207
+1,548
+18% +$97.9K
THRX
343
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
$626K 0.01%
232,693
– –
MA icon
344
Mastercard
MA
$502B
$618K 0.01%
1,561
-64
-4% -$25.7K
BDX icon
345
Becton Dickinson
BDX
$45.6B
$615K 0.01%
+2,377
New +$642K
BA icon
346
Boeing
BA
$171B
$595K 0.01%
3,103
– –
VRTX icon
347
Vertex Pharmaceuticals
VRTX
$119B
$587K 0.01%
1,688
– –
GOOG icon
348
Alphabet (Google) Class C
GOOG
$4.36T
$578K 0.01%
4,386
+271
+7% +$35.2K
BRK.B icon
349
Berkshire Hathaway Class B
BRK.B
$1.1T
$570K 0.01%
+1,628
New +$578K
PCAR icon
350
PACCAR
PCAR
$69.5B
$569K 0.01%
6,688
– –
12 13
14
15 16

Similar funds

CC
Centiva Capital New York $13.6B AUM 20% 1-Year Est. Return
PMAM
Picton Mahoney Asset Management Toronto, Ontario, Canada $13.5B AUM 50.48% 1-Year Est. Return
SA
Situational Awareness San Francisco, California $13.7B AUM 334.5% 1-Year Est. Return
PSCM
Pershing Square Capital Management New York $13.7B AUM 13.45% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return
AA
Acorns Advisers Irvine, California $13.5B AUM 15.15% 1-Year Est. Return
WA
Waverly Advisors Birmingham, Alabama $13.4B AUM 18.56% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

Driehaus Capital Management's Q3 2023 Portfolio in Review

As of Q3 2023, Driehaus Capital Management held 467 positions worth $7.69B, down 2.9% from $7.92B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Driehaus Capital Management's Q3 2023 filing shows 87 new, 134 increased, 143 reduced and 77 closed positions. Its largest new stake was Camtek: 1,412,510 shares worth $87.9M. The largest sale was DICE Therapeutics, Inc. Common Stock, an estimated $94.7M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Industrials and Healthcare.

  • Driehaus Capital Management's largest Q3 2023 buy was Camtek: 1,412,510 shares worth $87.9M.
  • Driehaus Capital Management added most to Structure Therapeutics in Q3 2023, an estimated $40.4M increase.
  • Driehaus Capital Management's biggest Q3 2023 reduction was Inspire Medical Systems, cutting an estimated $49M.
  • Driehaus Capital Management fully exited DICE Therapeutics, Inc. Common Stock in Q3 2023, selling an estimated $94.7M.
  • Driehaus Capital Management's ten largest holdings make up 18% of its $7.69B portfolio in Q3 2023.
  • Driehaus Capital Management opened 87 new positions and closed 77 in Q3 2023.
  • Driehaus Capital Management's portfolio value fell 2.9% quarter-over-quarter to $7.69B.

Based on Driehaus Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.